5-Bromo-6-chloropyridine-3-carboxylic acid → 5-bromo-6-chloro-N-(3-fluoro-4-((trifluoromethyl)thio)phenyl)nicotinamide
Reaktionsgleichung
[Br:1][C:2]1[C:3]([Cl:11])=[N:4][CH:5]=[C:6]([CH:10]=1)[C:7]([OH:9])=O.[F:12][C:13]1[CH:14]=[C:15]([CH:17]=[CH:18][C:19]=1[S:20][C:21]([F:24])([F:23])[F:22])[NH2:16]>>[Br:1][C:2]1[C:3]([Cl:11])=[N:4][CH:5]=[C:6]([CH:10]=1)[C:7]([NH:16][C:15]1[CH:17]=[CH:18][C:19]([S:20][C:21]([F:24])([F:22])[F:23])=[C:13]([F:12])[CH:14]=1)=[O:9]Komponenten
3
Versuchsvorschrift
The title compound was prepared in an analogous fashion to that described in Stage 185.2 using 5-bromo-6-chloro-nicotinic acid and 3-fluoro-4-trifluoromethylsulfanyl-aniline to afford a white crystalline solid. HPLC (Condition 4) tR=6.71 min, UPLC-MS (Condition 3) tR=1.34 min, m/z=429 [M−H]−.
Aufarbeitung
- customto afford a white crystalline solid
Quellen und Nachweise
- ORD-Eintrag
- ord-3d019a23b4f44b138437cfd9615387b6
- Quelldatensatz
- uspto-grants-2016_03
- Patentnummer
- US09278981B2
Notizen zur Reaktion
Wird geladen…